Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Index by author

December 01, 2005; Volume 33,Issue 12
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Anbazhagan, Mariappan

    1. You have access
      UNUSUAL DEHYDROXYLATION OF ANTIMICROBIAL AMIDOXIME PRODRUGS BY CYTOCHROME b5 AND NADH CYTOCHROME b5 REDUCTASE
      Janelle Y. Saulter, Joseph R. Kurian, Lauren A. Trepanier, Richard R. Tidwell, Arlene S. Bridges, David W. Boykin, Chad E. Stephens, Mariappan Anbazhagan and James Edwin Hall
      Drug Metabolism and Disposition December 2005, 33 (12) 1886-1893; DOI: https://doi.org/10.1124/dmd.105.005017
  2. Ando, Yuichi

    1. You have access
      GEFITINIB (IRESSA) INHIBITS THE CYP3A4-MEDIATED FORMATION OF 7-ETHYL-10-(4-AMINO-1-PIPERIDINO)CARBONYLOXYCAMPTOTHECIN BUT ACTIVATES THAT OF 7-ETHYL-10-[4-N-(5-AMINOPENTANOIC ACID)-1-PIPERIDINO]CARBONYLOXYCAMPTOTHECIN FROM IRINOTECAN
      Ken-ichi Fujita, Yuichi Ando, Masaru Narabayashi, Toshimichi Miya, Fumio Nagashima, Wataru Yamamoto, Keiji Kodama, Kazuhiro Araki, Hisashi Endo and Yasutsuna Sasaki
      Drug Metabolism and Disposition December 2005, 33 (12) 1785-1790; DOI: https://doi.org/10.1124/dmd.105.006205
  3. Anraku, Makoto

    1. You have access
      HYDROLYSIS OF ANGIOTENSIN II RECEPTOR BLOCKER PRODRUG OLMESARTAN MEDOXOMIL BY HUMAN SERUM ALBUMIN AND IDENTIFICATION OF ITS CATALYTIC ACTIVE SITES
      Shen-Feng Ma, Makoto Anraku, Yasunori Iwao, Keishi Yamasaki, Ulrich Kragh-Hansen, Noriyuki Yamaotsu, Shuichi Hirono, Toshihiko Ikeda and Masaki Otagiri
      Drug Metabolism and Disposition December 2005, 33 (12) 1911-1919; DOI: https://doi.org/10.1124/dmd.105.006163
  4. Aoki, Yasuhiro

    1. You have access
      CYP2A6 AND CYP2B6 ARE INVOLVED IN NORNICOTINE FORMATION FROM NICOTINE IN HUMANS: INTERINDIVIDUAL DIFFERENCES IN THESE CONTRIBUTIONS
      Hiroyuki Yamanaka, Miki Nakajima, Tatsuki Fukami, Haruko Sakai, Akiko Nakamura, Miki Katoh, Masataka Takamiya, Yasuhiro Aoki and Tsuyoshi Yokoi
      Drug Metabolism and Disposition December 2005, 33 (12) 1811-1818; DOI: https://doi.org/10.1124/dmd.105.006254
  5. Araki, Kazuhiro

    1. You have access
      GEFITINIB (IRESSA) INHIBITS THE CYP3A4-MEDIATED FORMATION OF 7-ETHYL-10-(4-AMINO-1-PIPERIDINO)CARBONYLOXYCAMPTOTHECIN BUT ACTIVATES THAT OF 7-ETHYL-10-[4-N-(5-AMINOPENTANOIC ACID)-1-PIPERIDINO]CARBONYLOXYCAMPTOTHECIN FROM IRINOTECAN
      Ken-ichi Fujita, Yuichi Ando, Masaru Narabayashi, Toshimichi Miya, Fumio Nagashima, Wataru Yamamoto, Keiji Kodama, Kazuhiro Araki, Hisashi Endo and Yasutsuna Sasaki
      Drug Metabolism and Disposition December 2005, 33 (12) 1785-1790; DOI: https://doi.org/10.1124/dmd.105.006205

B

  1. Bajimaya, Susan

    1. You have access
      DISPOSITION OF FLAVONOIDS VIA RECYCLING: COMPARISON OF INTESTINAL VERSUS HEPATIC DISPOSITION
      Jun Chen, Stephen Wang, Xiaobin Jia, Susan Bajimaya, Huimin Lin, Vincent H. Tam and Ming Hu
      Drug Metabolism and Disposition December 2005, 33 (12) 1777-1784; DOI: https://doi.org/10.1124/dmd.105.003673
  2. Beaune, Philippe

    1. You have access
      SIMULTANEOUS MEASUREMENT OF 23 ISOFORMS FROM THE HUMAN CYTOCHROME P450 FAMILIES 1 TO 3 BY QUANTITATIVE REVERSE TRANSCRIPTASE-POLYMERASE CHAIN REACTION
      Igor Girault, Nathalie Rougier, Christophe Chesné, Rosette Lidereau, Philippe Beaune, Ivan Bieche and Isabelle de Waziers
      Drug Metabolism and Disposition December 2005, 33 (12) 1803-1810; DOI: https://doi.org/10.1124/dmd.105.005173
  3. Bieche, Ivan

    1. You have access
      SIMULTANEOUS MEASUREMENT OF 23 ISOFORMS FROM THE HUMAN CYTOCHROME P450 FAMILIES 1 TO 3 BY QUANTITATIVE REVERSE TRANSCRIPTASE-POLYMERASE CHAIN REACTION
      Igor Girault, Nathalie Rougier, Christophe Chesné, Rosette Lidereau, Philippe Beaune, Ivan Bieche and Isabelle de Waziers
      Drug Metabolism and Disposition December 2005, 33 (12) 1803-1810; DOI: https://doi.org/10.1124/dmd.105.005173
  4. Boykin, David W.

    1. You have access
      UNUSUAL DEHYDROXYLATION OF ANTIMICROBIAL AMIDOXIME PRODRUGS BY CYTOCHROME b5 AND NADH CYTOCHROME b5 REDUCTASE
      Janelle Y. Saulter, Joseph R. Kurian, Lauren A. Trepanier, Richard R. Tidwell, Arlene S. Bridges, David W. Boykin, Chad E. Stephens, Mariappan Anbazhagan and James Edwin Hall
      Drug Metabolism and Disposition December 2005, 33 (12) 1886-1893; DOI: https://doi.org/10.1124/dmd.105.005017
  5. Bräter, M.

    1. You have access
      EFFECT OF PROPIVERINE ON CYTOCHROME P450 ENZYMES: A COCKTAIL INTERACTION STUDY IN HEALTHY VOLUNTEERS
      D. Tomalik-Scharte, A. Jetter, M. Kinzig-Schippers, A. Skott, F. Sörgel, T. Klaassen, D. Kasel, S. Harlfinger, O. Doroshyenko, D. Frank, J. Kirchheiner, M. Bräter, K. Richter, T. Gramatté and U. Fuhr
      Drug Metabolism and Disposition December 2005, 33 (12) 1859-1866; DOI: https://doi.org/10.1124/dmd.105.005272
  6. Bridges, Arlene S.

    1. You have access
      UNUSUAL DEHYDROXYLATION OF ANTIMICROBIAL AMIDOXIME PRODRUGS BY CYTOCHROME b5 AND NADH CYTOCHROME b5 REDUCTASE
      Janelle Y. Saulter, Joseph R. Kurian, Lauren A. Trepanier, Richard R. Tidwell, Arlene S. Bridges, David W. Boykin, Chad E. Stephens, Mariappan Anbazhagan and James Edwin Hall
      Drug Metabolism and Disposition December 2005, 33 (12) 1886-1893; DOI: https://doi.org/10.1124/dmd.105.005017
  7. Bu, Hai-Zhi

    1. You have access
      HUMAN IN VITRO GLUTATHIONYL AND PROTEIN ADDUCTS OF CARBAMAZEPINE-10,11-EPOXIDE, A STABLE AND PHARMACOLOGICALLY ACTIVE METABOLITE OF CARBAMAZEPINE
      Hai-Zhi Bu, Ping Kang, Alan J. Deese, Ping Zhao and William F. Pool
      Drug Metabolism and Disposition December 2005, 33 (12) 1920-1924; DOI: https://doi.org/10.1124/dmd.105.006866

C

  1. Caldwell, Gary W.

    1. You have access
      BIOACTIVATION OF 4-METHYLPHENOL (p-CRESOL) VIA CYTOCHROME P450-MEDIATED AROMATIC OXIDATION IN HUMAN LIVER MICROSOMES
      Zhengyin Yan, H. Marlon Zhong, Noureddine Maher, Rhoda Torres, Gregory C. Leo, Gary W. Caldwell and Norman Huebert
      Drug Metabolism and Disposition December 2005, 33 (12) 1867-1876; DOI: https://doi.org/10.1124/dmd.105.006387
  2. Cato, Brian

    1. You have access
      SPECIES DIFFERENCES IN THE ELIMINATION OF A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONIST HIGHLIGHTED BY OXIDATIVE METABOLISM OF ITS ACYL GLUCURONIDE
      Christopher J. Kochansky, Yuan-Qing Xia, Sui Wang, Brian Cato, Mellissa Creighton, Stella H. Vincent, Ronald B. Franklin and James R. Reed
      Drug Metabolism and Disposition December 2005, 33 (12) 1894-1904; DOI: https://doi.org/10.1124/dmd.105.004010
  3. Chen, Jun

    1. You have access
      DISPOSITION OF FLAVONOIDS VIA RECYCLING: COMPARISON OF INTESTINAL VERSUS HEPATIC DISPOSITION
      Jun Chen, Stephen Wang, Xiaobin Jia, Susan Bajimaya, Huimin Lin, Vincent H. Tam and Ming Hu
      Drug Metabolism and Disposition December 2005, 33 (12) 1777-1784; DOI: https://doi.org/10.1124/dmd.105.003673
  4. Chesné, Christophe

    1. You have access
      SIMULTANEOUS MEASUREMENT OF 23 ISOFORMS FROM THE HUMAN CYTOCHROME P450 FAMILIES 1 TO 3 BY QUANTITATIVE REVERSE TRANSCRIPTASE-POLYMERASE CHAIN REACTION
      Igor Girault, Nathalie Rougier, Christophe Chesné, Rosette Lidereau, Philippe Beaune, Ivan Bieche and Isabelle de Waziers
      Drug Metabolism and Disposition December 2005, 33 (12) 1803-1810; DOI: https://doi.org/10.1124/dmd.105.005173
  5. Chilakapati, Jaya

    1. You have access
      SATURATION TOXICOKINETICS OF THIOACETAMIDE: ROLE IN INITIATION OF LIVER INJURY
      Jaya Chilakapati, Kartik Shankar, Midhun C. Korrapati, Ronald A. Hill and Harihara M. Mehendale
      Drug Metabolism and Disposition December 2005, 33 (12) 1877-1885; DOI: https://doi.org/10.1124/dmd.105.005520
  6. Chun, Young-Jin

    1. You have access
      MODULATION OF HUMAN CYTOCHROME P450 1B1 EXPRESSION BY 2,4,3′,5′-TETRAMETHOXYSTILBENE
      Young-Jin Chun, Sang-Kwang Lee and Mie Young Kim
      Drug Metabolism and Disposition December 2005, 33 (12) 1771-1776; DOI: https://doi.org/10.1124/dmd.105.006502
  7. Court, Michael H.

    1. You have access
      ROLE OF THE NUCLEAR RECEPTOR PREGNANE X RECEPTOR IN ACETAMINOPHEN HEPATOTOXICITY
      Kristina K. Wolf, Sheryl G. Wood, Jane A. Hunt, Brooke W. Walton-Strong, Kazuto Yasuda, Lubin Lan, Su X. Duan, Qin Hao, Steven A. Wrighton, Elizabeth H. Jeffery, Ronald M. Evans, Juliana G. Szakacs, Lisa L. von Moltke, David J. Greenblatt, Michael H. Court, Erin G. Schuetz, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition December 2005, 33 (12) 1827-1836; DOI: https://doi.org/10.1124/dmd.105.005256
  8. Creighton, Mellissa

    1. You have access
      SPECIES DIFFERENCES IN THE ELIMINATION OF A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONIST HIGHLIGHTED BY OXIDATIVE METABOLISM OF ITS ACYL GLUCURONIDE
      Christopher J. Kochansky, Yuan-Qing Xia, Sui Wang, Brian Cato, Mellissa Creighton, Stella H. Vincent, Ronald B. Franklin and James R. Reed
      Drug Metabolism and Disposition December 2005, 33 (12) 1894-1904; DOI: https://doi.org/10.1124/dmd.105.004010
  9. Cui, Donghui

    1. You have access
      TRANSAMINATION IN THE METABOLISM OF THE NEPHROTOXICANT N-(3,5-DICHLOROPHENYL)SUCCINIMIDE IN RATS
      Donghui Cui, Gary O. Rankin and Peter J. Harvison
      Drug Metabolism and Disposition December 2005, 33 (12) 1765-1770; DOI: https://doi.org/10.1124/dmd.105.006593

D

  1. Deese, Alan J.

    1. You have access
      HUMAN IN VITRO GLUTATHIONYL AND PROTEIN ADDUCTS OF CARBAMAZEPINE-10,11-EPOXIDE, A STABLE AND PHARMACOLOGICALLY ACTIVE METABOLITE OF CARBAMAZEPINE
      Hai-Zhi Bu, Ping Kang, Alan J. Deese, Ping Zhao and William F. Pool
      Drug Metabolism and Disposition December 2005, 33 (12) 1920-1924; DOI: https://doi.org/10.1124/dmd.105.006866
  2. de Waziers, Isabelle

    1. You have access
      SIMULTANEOUS MEASUREMENT OF 23 ISOFORMS FROM THE HUMAN CYTOCHROME P450 FAMILIES 1 TO 3 BY QUANTITATIVE REVERSE TRANSCRIPTASE-POLYMERASE CHAIN REACTION
      Igor Girault, Nathalie Rougier, Christophe Chesné, Rosette Lidereau, Philippe Beaune, Ivan Bieche and Isabelle de Waziers
      Drug Metabolism and Disposition December 2005, 33 (12) 1803-1810; DOI: https://doi.org/10.1124/dmd.105.005173
  3. Dicke, Kari E.

    1. You have access
      NICOTINE AND 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-BUTANONE METABOLISM BY CYTOCHROME P450 2B6
      Kari E. Dicke, Sara M. Skrlin and Sharon E. Murphy
      Drug Metabolism and Disposition December 2005, 33 (12) 1760-1764; DOI: https://doi.org/10.1124/dmd.105.006718
  4. Doroshyenko, O.

    1. You have access
      EFFECT OF PROPIVERINE ON CYTOCHROME P450 ENZYMES: A COCKTAIL INTERACTION STUDY IN HEALTHY VOLUNTEERS
      D. Tomalik-Scharte, A. Jetter, M. Kinzig-Schippers, A. Skott, F. Sörgel, T. Klaassen, D. Kasel, S. Harlfinger, O. Doroshyenko, D. Frank, J. Kirchheiner, M. Bräter, K. Richter, T. Gramatté and U. Fuhr
      Drug Metabolism and Disposition December 2005, 33 (12) 1859-1866; DOI: https://doi.org/10.1124/dmd.105.005272
  5. Duan, Su X.

    1. You have access
      ROLE OF THE NUCLEAR RECEPTOR PREGNANE X RECEPTOR IN ACETAMINOPHEN HEPATOTOXICITY
      Kristina K. Wolf, Sheryl G. Wood, Jane A. Hunt, Brooke W. Walton-Strong, Kazuto Yasuda, Lubin Lan, Su X. Duan, Qin Hao, Steven A. Wrighton, Elizabeth H. Jeffery, Ronald M. Evans, Juliana G. Szakacs, Lisa L. von Moltke, David J. Greenblatt, Michael H. Court, Erin G. Schuetz, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition December 2005, 33 (12) 1827-1836; DOI: https://doi.org/10.1124/dmd.105.005256

E

  1. Endo, Hisashi

    1. You have access
      GEFITINIB (IRESSA) INHIBITS THE CYP3A4-MEDIATED FORMATION OF 7-ETHYL-10-(4-AMINO-1-PIPERIDINO)CARBONYLOXYCAMPTOTHECIN BUT ACTIVATES THAT OF 7-ETHYL-10-[4-N-(5-AMINOPENTANOIC ACID)-1-PIPERIDINO]CARBONYLOXYCAMPTOTHECIN FROM IRINOTECAN
      Ken-ichi Fujita, Yuichi Ando, Masaru Narabayashi, Toshimichi Miya, Fumio Nagashima, Wataru Yamamoto, Keiji Kodama, Kazuhiro Araki, Hisashi Endo and Yasutsuna Sasaki
      Drug Metabolism and Disposition December 2005, 33 (12) 1785-1790; DOI: https://doi.org/10.1124/dmd.105.006205
  2. Evans, Ronald M.

    1. You have access
      ROLE OF THE NUCLEAR RECEPTOR PREGNANE X RECEPTOR IN ACETAMINOPHEN HEPATOTOXICITY
      Kristina K. Wolf, Sheryl G. Wood, Jane A. Hunt, Brooke W. Walton-Strong, Kazuto Yasuda, Lubin Lan, Su X. Duan, Qin Hao, Steven A. Wrighton, Elizabeth H. Jeffery, Ronald M. Evans, Juliana G. Szakacs, Lisa L. von Moltke, David J. Greenblatt, Michael H. Court, Erin G. Schuetz, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition December 2005, 33 (12) 1827-1836; DOI: https://doi.org/10.1124/dmd.105.005256

F

  1. Frank, D.

    1. You have access
      EFFECT OF PROPIVERINE ON CYTOCHROME P450 ENZYMES: A COCKTAIL INTERACTION STUDY IN HEALTHY VOLUNTEERS
      D. Tomalik-Scharte, A. Jetter, M. Kinzig-Schippers, A. Skott, F. Sörgel, T. Klaassen, D. Kasel, S. Harlfinger, O. Doroshyenko, D. Frank, J. Kirchheiner, M. Bräter, K. Richter, T. Gramatté and U. Fuhr
      Drug Metabolism and Disposition December 2005, 33 (12) 1859-1866; DOI: https://doi.org/10.1124/dmd.105.005272
  2. Franklin, Ronald B.

    1. You have access
      SPECIES DIFFERENCES IN THE ELIMINATION OF A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONIST HIGHLIGHTED BY OXIDATIVE METABOLISM OF ITS ACYL GLUCURONIDE
      Christopher J. Kochansky, Yuan-Qing Xia, Sui Wang, Brian Cato, Mellissa Creighton, Stella H. Vincent, Ronald B. Franklin and James R. Reed
      Drug Metabolism and Disposition December 2005, 33 (12) 1894-1904; DOI: https://doi.org/10.1124/dmd.105.004010
  3. Fuhr, U.

    1. You have access
      EFFECT OF PROPIVERINE ON CYTOCHROME P450 ENZYMES: A COCKTAIL INTERACTION STUDY IN HEALTHY VOLUNTEERS
      D. Tomalik-Scharte, A. Jetter, M. Kinzig-Schippers, A. Skott, F. Sörgel, T. Klaassen, D. Kasel, S. Harlfinger, O. Doroshyenko, D. Frank, J. Kirchheiner, M. Bräter, K. Richter, T. Gramatté and U. Fuhr
      Drug Metabolism and Disposition December 2005, 33 (12) 1859-1866; DOI: https://doi.org/10.1124/dmd.105.005272
  4. Fujita, Ken-ichi

    1. You have access
      GEFITINIB (IRESSA) INHIBITS THE CYP3A4-MEDIATED FORMATION OF 7-ETHYL-10-(4-AMINO-1-PIPERIDINO)CARBONYLOXYCAMPTOTHECIN BUT ACTIVATES THAT OF 7-ETHYL-10-[4-N-(5-AMINOPENTANOIC ACID)-1-PIPERIDINO]CARBONYLOXYCAMPTOTHECIN FROM IRINOTECAN
      Ken-ichi Fujita, Yuichi Ando, Masaru Narabayashi, Toshimichi Miya, Fumio Nagashima, Wataru Yamamoto, Keiji Kodama, Kazuhiro Araki, Hisashi Endo and Yasutsuna Sasaki
      Drug Metabolism and Disposition December 2005, 33 (12) 1785-1790; DOI: https://doi.org/10.1124/dmd.105.006205
  5. Fukami, Tatsuki

    1. You have access
      CYP2A6 AND CYP2B6 ARE INVOLVED IN NORNICOTINE FORMATION FROM NICOTINE IN HUMANS: INTERINDIVIDUAL DIFFERENCES IN THESE CONTRIBUTIONS
      Hiroyuki Yamanaka, Miki Nakajima, Tatsuki Fukami, Haruko Sakai, Akiko Nakamura, Miki Katoh, Masataka Takamiya, Yasuhiro Aoki and Tsuyoshi Yokoi
      Drug Metabolism and Disposition December 2005, 33 (12) 1811-1818; DOI: https://doi.org/10.1124/dmd.105.006254

G

  1. Girault, Igor

    1. You have access
      SIMULTANEOUS MEASUREMENT OF 23 ISOFORMS FROM THE HUMAN CYTOCHROME P450 FAMILIES 1 TO 3 BY QUANTITATIVE REVERSE TRANSCRIPTASE-POLYMERASE CHAIN REACTION
      Igor Girault, Nathalie Rougier, Christophe Chesné, Rosette Lidereau, Philippe Beaune, Ivan Bieche and Isabelle de Waziers
      Drug Metabolism and Disposition December 2005, 33 (12) 1803-1810; DOI: https://doi.org/10.1124/dmd.105.005173
  2. Gramatté, T.

    1. You have access
      EFFECT OF PROPIVERINE ON CYTOCHROME P450 ENZYMES: A COCKTAIL INTERACTION STUDY IN HEALTHY VOLUNTEERS
      D. Tomalik-Scharte, A. Jetter, M. Kinzig-Schippers, A. Skott, F. Sörgel, T. Klaassen, D. Kasel, S. Harlfinger, O. Doroshyenko, D. Frank, J. Kirchheiner, M. Bräter, K. Richter, T. Gramatté and U. Fuhr
      Drug Metabolism and Disposition December 2005, 33 (12) 1859-1866; DOI: https://doi.org/10.1124/dmd.105.005272
  3. Greenblatt, David J.

    1. You have access
      ROLE OF THE NUCLEAR RECEPTOR PREGNANE X RECEPTOR IN ACETAMINOPHEN HEPATOTOXICITY
      Kristina K. Wolf, Sheryl G. Wood, Jane A. Hunt, Brooke W. Walton-Strong, Kazuto Yasuda, Lubin Lan, Su X. Duan, Qin Hao, Steven A. Wrighton, Elizabeth H. Jeffery, Ronald M. Evans, Juliana G. Szakacs, Lisa L. von Moltke, David J. Greenblatt, Michael H. Court, Erin G. Schuetz, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition December 2005, 33 (12) 1827-1836; DOI: https://doi.org/10.1124/dmd.105.005256

H

  1. Hakooz, Nancy

    1. You have access
      PREDICTION OF METABOLIC CLEARANCE USING CRYOPRESERVED HUMAN HEPATOCYTES: KINETIC CHARACTERISTICS FOR FIVE BENZODIAZEPINES
      David Hallifax, Helen C. Rawden, Nancy Hakooz and J. Brian Houston
      Drug Metabolism and Disposition December 2005, 33 (12) 1852-1858; DOI: https://doi.org/10.1124/dmd.105.005389
  2. Hall, James Edwin

    1. You have access
      UNUSUAL DEHYDROXYLATION OF ANTIMICROBIAL AMIDOXIME PRODRUGS BY CYTOCHROME b5 AND NADH CYTOCHROME b5 REDUCTASE
      Janelle Y. Saulter, Joseph R. Kurian, Lauren A. Trepanier, Richard R. Tidwell, Arlene S. Bridges, David W. Boykin, Chad E. Stephens, Mariappan Anbazhagan and James Edwin Hall
      Drug Metabolism and Disposition December 2005, 33 (12) 1886-1893; DOI: https://doi.org/10.1124/dmd.105.005017
  3. Hallifax, David

    1. You have access
      PREDICTION OF METABOLIC CLEARANCE USING CRYOPRESERVED HUMAN HEPATOCYTES: KINETIC CHARACTERISTICS FOR FIVE BENZODIAZEPINES
      David Hallifax, Helen C. Rawden, Nancy Hakooz and J. Brian Houston
      Drug Metabolism and Disposition December 2005, 33 (12) 1852-1858; DOI: https://doi.org/10.1124/dmd.105.005389
  4. Halpert, James R.

    1. You have access
      James R. Halpert
      Drug Metabolism and Disposition December 2005, 33 (12) 1759; DOI: https://doi.org/10.1124/dmd.33.12.1759
  5. Hanioka, Nobumitsu

    1. You have access
      FUNCTIONAL ANALYSIS OF THREE CYP1A2 VARIANTS FOUND IN A JAPANESE POPULATION
      Yoshiro Saito, Nobumitsu Hanioka, Keiko Maekawa, Takashi Isobe, Yumi Tsuneto, Ryosuke Nakamura, Akiko Soyama, Shogo Ozawa, Toshiko Tanaka-Kagawa, Hideto Jinno, Shizuo Narimatsu and Jun-ichi Sawada
      Drug Metabolism and Disposition December 2005, 33 (12) 1905-1910; DOI: https://doi.org/10.1124/dmd.105.005819
  6. Hao, Qin

    1. You have access
      ROLE OF THE NUCLEAR RECEPTOR PREGNANE X RECEPTOR IN ACETAMINOPHEN HEPATOTOXICITY
      Kristina K. Wolf, Sheryl G. Wood, Jane A. Hunt, Brooke W. Walton-Strong, Kazuto Yasuda, Lubin Lan, Su X. Duan, Qin Hao, Steven A. Wrighton, Elizabeth H. Jeffery, Ronald M. Evans, Juliana G. Szakacs, Lisa L. von Moltke, David J. Greenblatt, Michael H. Court, Erin G. Schuetz, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition December 2005, 33 (12) 1827-1836; DOI: https://doi.org/10.1124/dmd.105.005256
  7. Harlfinger, S.

    1. You have access
      EFFECT OF PROPIVERINE ON CYTOCHROME P450 ENZYMES: A COCKTAIL INTERACTION STUDY IN HEALTHY VOLUNTEERS
      D. Tomalik-Scharte, A. Jetter, M. Kinzig-Schippers, A. Skott, F. Sörgel, T. Klaassen, D. Kasel, S. Harlfinger, O. Doroshyenko, D. Frank, J. Kirchheiner, M. Bräter, K. Richter, T. Gramatté and U. Fuhr
      Drug Metabolism and Disposition December 2005, 33 (12) 1859-1866; DOI: https://doi.org/10.1124/dmd.105.005272
  8. Harvison, Peter J.

    1. You have access
      TRANSAMINATION IN THE METABOLISM OF THE NEPHROTOXICANT N-(3,5-DICHLOROPHENYL)SUCCINIMIDE IN RATS
      Donghui Cui, Gary O. Rankin and Peter J. Harvison
      Drug Metabolism and Disposition December 2005, 33 (12) 1765-1770; DOI: https://doi.org/10.1124/dmd.105.006593
  9. Hill, Ronald A.

    1. You have access
      SATURATION TOXICOKINETICS OF THIOACETAMIDE: ROLE IN INITIATION OF LIVER INJURY
      Jaya Chilakapati, Kartik Shankar, Midhun C. Korrapati, Ronald A. Hill and Harihara M. Mehendale
      Drug Metabolism and Disposition December 2005, 33 (12) 1877-1885; DOI: https://doi.org/10.1124/dmd.105.005520
  10. Hirayama, Masamichi

    1. You have access
      INVOLVEMENT OF URIC ACID TRANSPORTER IN INCREASED RENAL CLEARANCE OF THE XANTHINE OXIDASE INHIBITOR OXYPURINOL INDUCED BY A URICOSURIC AGENT, BENZBROMARONE
      Takashi Iwanaga, Daisuke Kobayashi, Masamichi Hirayama, Tomoji Maeda and Ikumi Tamai
      Drug Metabolism and Disposition December 2005, 33 (12) 1791-1795; DOI: https://doi.org/10.1124/dmd.105.006056
  11. Hirono, Shuichi

    1. You have access
      HYDROLYSIS OF ANGIOTENSIN II RECEPTOR BLOCKER PRODRUG OLMESARTAN MEDOXOMIL BY HUMAN SERUM ALBUMIN AND IDENTIFICATION OF ITS CATALYTIC ACTIVE SITES
      Shen-Feng Ma, Makoto Anraku, Yasunori Iwao, Keishi Yamasaki, Ulrich Kragh-Hansen, Noriyuki Yamaotsu, Shuichi Hirono, Toshihiko Ikeda and Masaki Otagiri
      Drug Metabolism and Disposition December 2005, 33 (12) 1911-1919; DOI: https://doi.org/10.1124/dmd.105.006163
  12. Houston, J. Brian

    1. You have access
      PREDICTION OF METABOLIC CLEARANCE USING CRYOPRESERVED HUMAN HEPATOCYTES: KINETIC CHARACTERISTICS FOR FIVE BENZODIAZEPINES
      David Hallifax, Helen C. Rawden, Nancy Hakooz and J. Brian Houston
      Drug Metabolism and Disposition December 2005, 33 (12) 1852-1858; DOI: https://doi.org/10.1124/dmd.105.005389
  13. Hu, Ming

    1. You have access
      DISPOSITION OF FLAVONOIDS VIA RECYCLING: COMPARISON OF INTESTINAL VERSUS HEPATIC DISPOSITION
      Jun Chen, Stephen Wang, Xiaobin Jia, Susan Bajimaya, Huimin Lin, Vincent H. Tam and Ming Hu
      Drug Metabolism and Disposition December 2005, 33 (12) 1777-1784; DOI: https://doi.org/10.1124/dmd.105.003673
  14. Huebert, Norman

    1. You have access
      BIOACTIVATION OF 4-METHYLPHENOL (p-CRESOL) VIA CYTOCHROME P450-MEDIATED AROMATIC OXIDATION IN HUMAN LIVER MICROSOMES
      Zhengyin Yan, H. Marlon Zhong, Noureddine Maher, Rhoda Torres, Gregory C. Leo, Gary W. Caldwell and Norman Huebert
      Drug Metabolism and Disposition December 2005, 33 (12) 1867-1876; DOI: https://doi.org/10.1124/dmd.105.006387
  15. Hunt, Jane A.

    1. You have access
      ROLE OF THE NUCLEAR RECEPTOR PREGNANE X RECEPTOR IN ACETAMINOPHEN HEPATOTOXICITY
      Kristina K. Wolf, Sheryl G. Wood, Jane A. Hunt, Brooke W. Walton-Strong, Kazuto Yasuda, Lubin Lan, Su X. Duan, Qin Hao, Steven A. Wrighton, Elizabeth H. Jeffery, Ronald M. Evans, Juliana G. Szakacs, Lisa L. von Moltke, David J. Greenblatt, Michael H. Court, Erin G. Schuetz, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition December 2005, 33 (12) 1827-1836; DOI: https://doi.org/10.1124/dmd.105.005256

I

  1. Ikeda, Toshihiko

    1. You have access
      HYDROLYSIS OF ANGIOTENSIN II RECEPTOR BLOCKER PRODRUG OLMESARTAN MEDOXOMIL BY HUMAN SERUM ALBUMIN AND IDENTIFICATION OF ITS CATALYTIC ACTIVE SITES
      Shen-Feng Ma, Makoto Anraku, Yasunori Iwao, Keishi Yamasaki, Ulrich Kragh-Hansen, Noriyuki Yamaotsu, Shuichi Hirono, Toshihiko Ikeda and Masaki Otagiri
      Drug Metabolism and Disposition December 2005, 33 (12) 1911-1919; DOI: https://doi.org/10.1124/dmd.105.006163
  2. Isobe, Takashi

    1. You have access
      FUNCTIONAL ANALYSIS OF THREE CYP1A2 VARIANTS FOUND IN A JAPANESE POPULATION
      Yoshiro Saito, Nobumitsu Hanioka, Keiko Maekawa, Takashi Isobe, Yumi Tsuneto, Ryosuke Nakamura, Akiko Soyama, Shogo Ozawa, Toshiko Tanaka-Kagawa, Hideto Jinno, Shizuo Narimatsu and Jun-ichi Sawada
      Drug Metabolism and Disposition December 2005, 33 (12) 1905-1910; DOI: https://doi.org/10.1124/dmd.105.005819
  3. Iwanaga, Takashi

    1. You have access
      INVOLVEMENT OF URIC ACID TRANSPORTER IN INCREASED RENAL CLEARANCE OF THE XANTHINE OXIDASE INHIBITOR OXYPURINOL INDUCED BY A URICOSURIC AGENT, BENZBROMARONE
      Takashi Iwanaga, Daisuke Kobayashi, Masamichi Hirayama, Tomoji Maeda and Ikumi Tamai
      Drug Metabolism and Disposition December 2005, 33 (12) 1791-1795; DOI: https://doi.org/10.1124/dmd.105.006056
  4. Iwao, Yasunori

    1. You have access
      HYDROLYSIS OF ANGIOTENSIN II RECEPTOR BLOCKER PRODRUG OLMESARTAN MEDOXOMIL BY HUMAN SERUM ALBUMIN AND IDENTIFICATION OF ITS CATALYTIC ACTIVE SITES
      Shen-Feng Ma, Makoto Anraku, Yasunori Iwao, Keishi Yamasaki, Ulrich Kragh-Hansen, Noriyuki Yamaotsu, Shuichi Hirono, Toshihiko Ikeda and Masaki Otagiri
      Drug Metabolism and Disposition December 2005, 33 (12) 1911-1919; DOI: https://doi.org/10.1124/dmd.105.006163

J

  1. Jeffery, Elizabeth H.

    1. You have access
      ROLE OF THE NUCLEAR RECEPTOR PREGNANE X RECEPTOR IN ACETAMINOPHEN HEPATOTOXICITY
      Kristina K. Wolf, Sheryl G. Wood, Jane A. Hunt, Brooke W. Walton-Strong, Kazuto Yasuda, Lubin Lan, Su X. Duan, Qin Hao, Steven A. Wrighton, Elizabeth H. Jeffery, Ronald M. Evans, Juliana G. Szakacs, Lisa L. von Moltke, David J. Greenblatt, Michael H. Court, Erin G. Schuetz, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition December 2005, 33 (12) 1827-1836; DOI: https://doi.org/10.1124/dmd.105.005256
  2. Jetter, A.

    1. You have access
      EFFECT OF PROPIVERINE ON CYTOCHROME P450 ENZYMES: A COCKTAIL INTERACTION STUDY IN HEALTHY VOLUNTEERS
      D. Tomalik-Scharte, A. Jetter, M. Kinzig-Schippers, A. Skott, F. Sörgel, T. Klaassen, D. Kasel, S. Harlfinger, O. Doroshyenko, D. Frank, J. Kirchheiner, M. Bräter, K. Richter, T. Gramatté and U. Fuhr
      Drug Metabolism and Disposition December 2005, 33 (12) 1859-1866; DOI: https://doi.org/10.1124/dmd.105.005272
  3. Jia, Xiaobin

    1. You have access
      DISPOSITION OF FLAVONOIDS VIA RECYCLING: COMPARISON OF INTESTINAL VERSUS HEPATIC DISPOSITION
      Jun Chen, Stephen Wang, Xiaobin Jia, Susan Bajimaya, Huimin Lin, Vincent H. Tam and Ming Hu
      Drug Metabolism and Disposition December 2005, 33 (12) 1777-1784; DOI: https://doi.org/10.1124/dmd.105.003673
  4. Jinno, Hideto

    1. You have access
      FUNCTIONAL ANALYSIS OF THREE CYP1A2 VARIANTS FOUND IN A JAPANESE POPULATION
      Yoshiro Saito, Nobumitsu Hanioka, Keiko Maekawa, Takashi Isobe, Yumi Tsuneto, Ryosuke Nakamura, Akiko Soyama, Shogo Ozawa, Toshiko Tanaka-Kagawa, Hideto Jinno, Shizuo Narimatsu and Jun-ichi Sawada
      Drug Metabolism and Disposition December 2005, 33 (12) 1905-1910; DOI: https://doi.org/10.1124/dmd.105.005819

K

  1. Kang, Ping

    1. You have access
      HUMAN IN VITRO GLUTATHIONYL AND PROTEIN ADDUCTS OF CARBAMAZEPINE-10,11-EPOXIDE, A STABLE AND PHARMACOLOGICALLY ACTIVE METABOLITE OF CARBAMAZEPINE
      Hai-Zhi Bu, Ping Kang, Alan J. Deese, Ping Zhao and William F. Pool
      Drug Metabolism and Disposition December 2005, 33 (12) 1920-1924; DOI: https://doi.org/10.1124/dmd.105.006866
  2. Kasel, D.

    1. You have access
      EFFECT OF PROPIVERINE ON CYTOCHROME P450 ENZYMES: A COCKTAIL INTERACTION STUDY IN HEALTHY VOLUNTEERS
      D. Tomalik-Scharte, A. Jetter, M. Kinzig-Schippers, A. Skott, F. Sörgel, T. Klaassen, D. Kasel, S. Harlfinger, O. Doroshyenko, D. Frank, J. Kirchheiner, M. Bräter, K. Richter, T. Gramatté and U. Fuhr
      Drug Metabolism and Disposition December 2005, 33 (12) 1859-1866; DOI: https://doi.org/10.1124/dmd.105.005272
  3. Katoh, Miki

    1. You have access
      CYP2A6 AND CYP2B6 ARE INVOLVED IN NORNICOTINE FORMATION FROM NICOTINE IN HUMANS: INTERINDIVIDUAL DIFFERENCES IN THESE CONTRIBUTIONS
      Hiroyuki Yamanaka, Miki Nakajima, Tatsuki Fukami, Haruko Sakai, Akiko Nakamura, Miki Katoh, Masataka Takamiya, Yasuhiro Aoki and Tsuyoshi Yokoi
      Drug Metabolism and Disposition December 2005, 33 (12) 1811-1818; DOI: https://doi.org/10.1124/dmd.105.006254
  4. Kim, Mie Young

    1. You have access
      MODULATION OF HUMAN CYTOCHROME P450 1B1 EXPRESSION BY 2,4,3′,5′-TETRAMETHOXYSTILBENE
      Young-Jin Chun, Sang-Kwang Lee and Mie Young Kim
      Drug Metabolism and Disposition December 2005, 33 (12) 1771-1776; DOI: https://doi.org/10.1124/dmd.105.006502
  5. Kinzig-Schippers, M.

    1. You have access
      EFFECT OF PROPIVERINE ON CYTOCHROME P450 ENZYMES: A COCKTAIL INTERACTION STUDY IN HEALTHY VOLUNTEERS
      D. Tomalik-Scharte, A. Jetter, M. Kinzig-Schippers, A. Skott, F. Sörgel, T. Klaassen, D. Kasel, S. Harlfinger, O. Doroshyenko, D. Frank, J. Kirchheiner, M. Bräter, K. Richter, T. Gramatté and U. Fuhr
      Drug Metabolism and Disposition December 2005, 33 (12) 1859-1866; DOI: https://doi.org/10.1124/dmd.105.005272
  6. Kirchheiner, J.

    1. You have access
      EFFECT OF PROPIVERINE ON CYTOCHROME P450 ENZYMES: A COCKTAIL INTERACTION STUDY IN HEALTHY VOLUNTEERS
      D. Tomalik-Scharte, A. Jetter, M. Kinzig-Schippers, A. Skott, F. Sörgel, T. Klaassen, D. Kasel, S. Harlfinger, O. Doroshyenko, D. Frank, J. Kirchheiner, M. Bräter, K. Richter, T. Gramatté and U. Fuhr
      Drug Metabolism and Disposition December 2005, 33 (12) 1859-1866; DOI: https://doi.org/10.1124/dmd.105.005272
  7. Klaassen, T.

    1. You have access
      EFFECT OF PROPIVERINE ON CYTOCHROME P450 ENZYMES: A COCKTAIL INTERACTION STUDY IN HEALTHY VOLUNTEERS
      D. Tomalik-Scharte, A. Jetter, M. Kinzig-Schippers, A. Skott, F. Sörgel, T. Klaassen, D. Kasel, S. Harlfinger, O. Doroshyenko, D. Frank, J. Kirchheiner, M. Bräter, K. Richter, T. Gramatté and U. Fuhr
      Drug Metabolism and Disposition December 2005, 33 (12) 1859-1866; DOI: https://doi.org/10.1124/dmd.105.005272
  8. Kobayashi, Daisuke

    1. You have access
      INVOLVEMENT OF URIC ACID TRANSPORTER IN INCREASED RENAL CLEARANCE OF THE XANTHINE OXIDASE INHIBITOR OXYPURINOL INDUCED BY A URICOSURIC AGENT, BENZBROMARONE
      Takashi Iwanaga, Daisuke Kobayashi, Masamichi Hirayama, Tomoji Maeda and Ikumi Tamai
      Drug Metabolism and Disposition December 2005, 33 (12) 1791-1795; DOI: https://doi.org/10.1124/dmd.105.006056
  9. Kobayashi, Yasuna

    1. You have access
      FUNCTIONAL CHARACTERIZATION OF HUMAN MONOCARBOXYLATE TRANSPORTER 6 (SLC16A5)
      Yuichi Murakami, Noriko Kohyama, Yasuna Kobayashi, Masayuki Ohbayashi, Hisakazu Ohtani, Yasufumi Sawada and Toshinori Yamamoto
      Drug Metabolism and Disposition December 2005, 33 (12) 1845-1851; DOI: https://doi.org/10.1124/dmd.105.005264
  10. Kochansky, Christopher J.

    1. You have access
      SPECIES DIFFERENCES IN THE ELIMINATION OF A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONIST HIGHLIGHTED BY OXIDATIVE METABOLISM OF ITS ACYL GLUCURONIDE
      Christopher J. Kochansky, Yuan-Qing Xia, Sui Wang, Brian Cato, Mellissa Creighton, Stella H. Vincent, Ronald B. Franklin and James R. Reed
      Drug Metabolism and Disposition December 2005, 33 (12) 1894-1904; DOI: https://doi.org/10.1124/dmd.105.004010
  11. Kodama, Keiji

    1. You have access
      GEFITINIB (IRESSA) INHIBITS THE CYP3A4-MEDIATED FORMATION OF 7-ETHYL-10-(4-AMINO-1-PIPERIDINO)CARBONYLOXYCAMPTOTHECIN BUT ACTIVATES THAT OF 7-ETHYL-10-[4-N-(5-AMINOPENTANOIC ACID)-1-PIPERIDINO]CARBONYLOXYCAMPTOTHECIN FROM IRINOTECAN
      Ken-ichi Fujita, Yuichi Ando, Masaru Narabayashi, Toshimichi Miya, Fumio Nagashima, Wataru Yamamoto, Keiji Kodama, Kazuhiro Araki, Hisashi Endo and Yasutsuna Sasaki
      Drug Metabolism and Disposition December 2005, 33 (12) 1785-1790; DOI: https://doi.org/10.1124/dmd.105.006205
  12. Kohyama, Noriko

    1. You have access
      FUNCTIONAL CHARACTERIZATION OF HUMAN MONOCARBOXYLATE TRANSPORTER 6 (SLC16A5)
      Yuichi Murakami, Noriko Kohyama, Yasuna Kobayashi, Masayuki Ohbayashi, Hisakazu Ohtani, Yasufumi Sawada and Toshinori Yamamoto
      Drug Metabolism and Disposition December 2005, 33 (12) 1845-1851; DOI: https://doi.org/10.1124/dmd.105.005264
  13. Korrapati, Midhun C.

    1. You have access
      SATURATION TOXICOKINETICS OF THIOACETAMIDE: ROLE IN INITIATION OF LIVER INJURY
      Jaya Chilakapati, Kartik Shankar, Midhun C. Korrapati, Ronald A. Hill and Harihara M. Mehendale
      Drug Metabolism and Disposition December 2005, 33 (12) 1877-1885; DOI: https://doi.org/10.1124/dmd.105.005520
  14. Kragh-Hansen, Ulrich

    1. You have access
      HYDROLYSIS OF ANGIOTENSIN II RECEPTOR BLOCKER PRODRUG OLMESARTAN MEDOXOMIL BY HUMAN SERUM ALBUMIN AND IDENTIFICATION OF ITS CATALYTIC ACTIVE SITES
      Shen-Feng Ma, Makoto Anraku, Yasunori Iwao, Keishi Yamasaki, Ulrich Kragh-Hansen, Noriyuki Yamaotsu, Shuichi Hirono, Toshihiko Ikeda and Masaki Otagiri
      Drug Metabolism and Disposition December 2005, 33 (12) 1911-1919; DOI: https://doi.org/10.1124/dmd.105.006163
  15. Kunze, Kent L.

    1. You have access
      OXIDATION OF CAFFEINE BY CYP1A2: ISOTOPE EFFECTS AND METABOLIC SWITCHING
      Kelly A. Regal, Kent L. Kunze, Raimund M. Peter and Sidney D. Nelson
      Drug Metabolism and Disposition December 2005, 33 (12) 1837-1844; DOI: https://doi.org/10.1124/dmd.105.006031
  16. Kurian, Joseph R.

    1. You have access
      UNUSUAL DEHYDROXYLATION OF ANTIMICROBIAL AMIDOXIME PRODRUGS BY CYTOCHROME b5 AND NADH CYTOCHROME b5 REDUCTASE
      Janelle Y. Saulter, Joseph R. Kurian, Lauren A. Trepanier, Richard R. Tidwell, Arlene S. Bridges, David W. Boykin, Chad E. Stephens, Mariappan Anbazhagan and James Edwin Hall
      Drug Metabolism and Disposition December 2005, 33 (12) 1886-1893; DOI: https://doi.org/10.1124/dmd.105.005017

L

  1. Lan, Lubin

    1. You have access
      ROLE OF THE NUCLEAR RECEPTOR PREGNANE X RECEPTOR IN ACETAMINOPHEN HEPATOTOXICITY
      Kristina K. Wolf, Sheryl G. Wood, Jane A. Hunt, Brooke W. Walton-Strong, Kazuto Yasuda, Lubin Lan, Su X. Duan, Qin Hao, Steven A. Wrighton, Elizabeth H. Jeffery, Ronald M. Evans, Juliana G. Szakacs, Lisa L. von Moltke, David J. Greenblatt, Michael H. Court, Erin G. Schuetz, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition December 2005, 33 (12) 1827-1836; DOI: https://doi.org/10.1124/dmd.105.005256
  2. Lee, Sang-Kwang

    1. You have access
      MODULATION OF HUMAN CYTOCHROME P450 1B1 EXPRESSION BY 2,4,3′,5′-TETRAMETHOXYSTILBENE
      Young-Jin Chun, Sang-Kwang Lee and Mie Young Kim
      Drug Metabolism and Disposition December 2005, 33 (12) 1771-1776; DOI: https://doi.org/10.1124/dmd.105.006502
  3. Leeder, J. Steven

    1. You have access
      PATHWAYS OF CARBAMAZEPINE BIOACTIVATION IN VITRO: II. THE ROLE OF HUMAN CYTOCHROME P450 ENZYMES IN THE FORMATION OF 2-HYDROXYIMINOSTILBENE
      Robin E. Pearce, Jack P. Uetrecht and J. Steven Leeder
      Drug Metabolism and Disposition December 2005, 33 (12) 1819-1826; DOI: https://doi.org/10.1124/dmd.105.004861
  4. Leo, Gregory C.

    1. You have access
      BIOACTIVATION OF 4-METHYLPHENOL (p-CRESOL) VIA CYTOCHROME P450-MEDIATED AROMATIC OXIDATION IN HUMAN LIVER MICROSOMES
      Zhengyin Yan, H. Marlon Zhong, Noureddine Maher, Rhoda Torres, Gregory C. Leo, Gary W. Caldwell and Norman Huebert
      Drug Metabolism and Disposition December 2005, 33 (12) 1867-1876; DOI: https://doi.org/10.1124/dmd.105.006387
  5. Lidereau, Rosette

    1. You have access
      SIMULTANEOUS MEASUREMENT OF 23 ISOFORMS FROM THE HUMAN CYTOCHROME P450 FAMILIES 1 TO 3 BY QUANTITATIVE REVERSE TRANSCRIPTASE-POLYMERASE CHAIN REACTION
      Igor Girault, Nathalie Rougier, Christophe Chesné, Rosette Lidereau, Philippe Beaune, Ivan Bieche and Isabelle de Waziers
      Drug Metabolism and Disposition December 2005, 33 (12) 1803-1810; DOI: https://doi.org/10.1124/dmd.105.005173
  6. Lin, Huimin

    1. You have access
      DISPOSITION OF FLAVONOIDS VIA RECYCLING: COMPARISON OF INTESTINAL VERSUS HEPATIC DISPOSITION
      Jun Chen, Stephen Wang, Xiaobin Jia, Susan Bajimaya, Huimin Lin, Vincent H. Tam and Ming Hu
      Drug Metabolism and Disposition December 2005, 33 (12) 1777-1784; DOI: https://doi.org/10.1124/dmd.105.003673

M

  1. Ma, Bennett

    1. You have access
      GLYCOSIDATION OF AN ENDOTHELIN ETA RECEPTOR ANTAGONIST AND DICLOFENAC IN HUMAN LIVER MICROSOMES: AGLYCONE-DEPENDENT UDP-SUGAR SELECTIVITY
      Cuyue Tang and Bennett Ma
      Drug Metabolism and Disposition December 2005, 33 (12) 1796-1802; DOI: https://doi.org/10.1124/dmd.105.005801
  2. Ma, Shen-Feng

    1. You have access
      HYDROLYSIS OF ANGIOTENSIN II RECEPTOR BLOCKER PRODRUG OLMESARTAN MEDOXOMIL BY HUMAN SERUM ALBUMIN AND IDENTIFICATION OF ITS CATALYTIC ACTIVE SITES
      Shen-Feng Ma, Makoto Anraku, Yasunori Iwao, Keishi Yamasaki, Ulrich Kragh-Hansen, Noriyuki Yamaotsu, Shuichi Hirono, Toshihiko Ikeda and Masaki Otagiri
      Drug Metabolism and Disposition December 2005, 33 (12) 1911-1919; DOI: https://doi.org/10.1124/dmd.105.006163
  3. Maeda, Tomoji

    1. You have access
      INVOLVEMENT OF URIC ACID TRANSPORTER IN INCREASED RENAL CLEARANCE OF THE XANTHINE OXIDASE INHIBITOR OXYPURINOL INDUCED BY A URICOSURIC AGENT, BENZBROMARONE
      Takashi Iwanaga, Daisuke Kobayashi, Masamichi Hirayama, Tomoji Maeda and Ikumi Tamai
      Drug Metabolism and Disposition December 2005, 33 (12) 1791-1795; DOI: https://doi.org/10.1124/dmd.105.006056
  4. Maekawa, Keiko

    1. You have access
      FUNCTIONAL ANALYSIS OF THREE CYP1A2 VARIANTS FOUND IN A JAPANESE POPULATION
      Yoshiro Saito, Nobumitsu Hanioka, Keiko Maekawa, Takashi Isobe, Yumi Tsuneto, Ryosuke Nakamura, Akiko Soyama, Shogo Ozawa, Toshiko Tanaka-Kagawa, Hideto Jinno, Shizuo Narimatsu and Jun-ichi Sawada
      Drug Metabolism and Disposition December 2005, 33 (12) 1905-1910; DOI: https://doi.org/10.1124/dmd.105.005819
  5. Maher, Noureddine

    1. You have access
      BIOACTIVATION OF 4-METHYLPHENOL (p-CRESOL) VIA CYTOCHROME P450-MEDIATED AROMATIC OXIDATION IN HUMAN LIVER MICROSOMES
      Zhengyin Yan, H. Marlon Zhong, Noureddine Maher, Rhoda Torres, Gregory C. Leo, Gary W. Caldwell and Norman Huebert
      Drug Metabolism and Disposition December 2005, 33 (12) 1867-1876; DOI: https://doi.org/10.1124/dmd.105.006387
  6. Mehendale, Harihara M.

    1. You have access
      SATURATION TOXICOKINETICS OF THIOACETAMIDE: ROLE IN INITIATION OF LIVER INJURY
      Jaya Chilakapati, Kartik Shankar, Midhun C. Korrapati, Ronald A. Hill and Harihara M. Mehendale
      Drug Metabolism and Disposition December 2005, 33 (12) 1877-1885; DOI: https://doi.org/10.1124/dmd.105.005520
  7. Miya, Toshimichi

    1. You have access
      GEFITINIB (IRESSA) INHIBITS THE CYP3A4-MEDIATED FORMATION OF 7-ETHYL-10-(4-AMINO-1-PIPERIDINO)CARBONYLOXYCAMPTOTHECIN BUT ACTIVATES THAT OF 7-ETHYL-10-[4-N-(5-AMINOPENTANOIC ACID)-1-PIPERIDINO]CARBONYLOXYCAMPTOTHECIN FROM IRINOTECAN
      Ken-ichi Fujita, Yuichi Ando, Masaru Narabayashi, Toshimichi Miya, Fumio Nagashima, Wataru Yamamoto, Keiji Kodama, Kazuhiro Araki, Hisashi Endo and Yasutsuna Sasaki
      Drug Metabolism and Disposition December 2005, 33 (12) 1785-1790; DOI: https://doi.org/10.1124/dmd.105.006205
  8. Murakami, Yuichi

    1. You have access
      FUNCTIONAL CHARACTERIZATION OF HUMAN MONOCARBOXYLATE TRANSPORTER 6 (SLC16A5)
      Yuichi Murakami, Noriko Kohyama, Yasuna Kobayashi, Masayuki Ohbayashi, Hisakazu Ohtani, Yasufumi Sawada and Toshinori Yamamoto
      Drug Metabolism and Disposition December 2005, 33 (12) 1845-1851; DOI: https://doi.org/10.1124/dmd.105.005264
  9. Murphy, Sharon E.

    1. You have access
      NICOTINE AND 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-BUTANONE METABOLISM BY CYTOCHROME P450 2B6
      Kari E. Dicke, Sara M. Skrlin and Sharon E. Murphy
      Drug Metabolism and Disposition December 2005, 33 (12) 1760-1764; DOI: https://doi.org/10.1124/dmd.105.006718

N

  1. Nagashima, Fumio

    1. You have access
      GEFITINIB (IRESSA) INHIBITS THE CYP3A4-MEDIATED FORMATION OF 7-ETHYL-10-(4-AMINO-1-PIPERIDINO)CARBONYLOXYCAMPTOTHECIN BUT ACTIVATES THAT OF 7-ETHYL-10-[4-N-(5-AMINOPENTANOIC ACID)-1-PIPERIDINO]CARBONYLOXYCAMPTOTHECIN FROM IRINOTECAN
      Ken-ichi Fujita, Yuichi Ando, Masaru Narabayashi, Toshimichi Miya, Fumio Nagashima, Wataru Yamamoto, Keiji Kodama, Kazuhiro Araki, Hisashi Endo and Yasutsuna Sasaki
      Drug Metabolism and Disposition December 2005, 33 (12) 1785-1790; DOI: https://doi.org/10.1124/dmd.105.006205
  2. Nakajima, Miki

    1. You have access
      CYP2A6 AND CYP2B6 ARE INVOLVED IN NORNICOTINE FORMATION FROM NICOTINE IN HUMANS: INTERINDIVIDUAL DIFFERENCES IN THESE CONTRIBUTIONS
      Hiroyuki Yamanaka, Miki Nakajima, Tatsuki Fukami, Haruko Sakai, Akiko Nakamura, Miki Katoh, Masataka Takamiya, Yasuhiro Aoki and Tsuyoshi Yokoi
      Drug Metabolism and Disposition December 2005, 33 (12) 1811-1818; DOI: https://doi.org/10.1124/dmd.105.006254
  3. Nakamura, Akiko

    1. You have access
      CYP2A6 AND CYP2B6 ARE INVOLVED IN NORNICOTINE FORMATION FROM NICOTINE IN HUMANS: INTERINDIVIDUAL DIFFERENCES IN THESE CONTRIBUTIONS
      Hiroyuki Yamanaka, Miki Nakajima, Tatsuki Fukami, Haruko Sakai, Akiko Nakamura, Miki Katoh, Masataka Takamiya, Yasuhiro Aoki and Tsuyoshi Yokoi
      Drug Metabolism and Disposition December 2005, 33 (12) 1811-1818; DOI: https://doi.org/10.1124/dmd.105.006254
  4. Nakamura, Ryosuke

    1. You have access
      FUNCTIONAL ANALYSIS OF THREE CYP1A2 VARIANTS FOUND IN A JAPANESE POPULATION
      Yoshiro Saito, Nobumitsu Hanioka, Keiko Maekawa, Takashi Isobe, Yumi Tsuneto, Ryosuke Nakamura, Akiko Soyama, Shogo Ozawa, Toshiko Tanaka-Kagawa, Hideto Jinno, Shizuo Narimatsu and Jun-ichi Sawada
      Drug Metabolism and Disposition December 2005, 33 (12) 1905-1910; DOI: https://doi.org/10.1124/dmd.105.005819
  5. Narabayashi, Masaru

    1. You have access
      GEFITINIB (IRESSA) INHIBITS THE CYP3A4-MEDIATED FORMATION OF 7-ETHYL-10-(4-AMINO-1-PIPERIDINO)CARBONYLOXYCAMPTOTHECIN BUT ACTIVATES THAT OF 7-ETHYL-10-[4-N-(5-AMINOPENTANOIC ACID)-1-PIPERIDINO]CARBONYLOXYCAMPTOTHECIN FROM IRINOTECAN
      Ken-ichi Fujita, Yuichi Ando, Masaru Narabayashi, Toshimichi Miya, Fumio Nagashima, Wataru Yamamoto, Keiji Kodama, Kazuhiro Araki, Hisashi Endo and Yasutsuna Sasaki
      Drug Metabolism and Disposition December 2005, 33 (12) 1785-1790; DOI: https://doi.org/10.1124/dmd.105.006205
  6. Narimatsu, Shizuo

    1. You have access
      FUNCTIONAL ANALYSIS OF THREE CYP1A2 VARIANTS FOUND IN A JAPANESE POPULATION
      Yoshiro Saito, Nobumitsu Hanioka, Keiko Maekawa, Takashi Isobe, Yumi Tsuneto, Ryosuke Nakamura, Akiko Soyama, Shogo Ozawa, Toshiko Tanaka-Kagawa, Hideto Jinno, Shizuo Narimatsu and Jun-ichi Sawada
      Drug Metabolism and Disposition December 2005, 33 (12) 1905-1910; DOI: https://doi.org/10.1124/dmd.105.005819
  7. Nelson, Sidney D.

    1. You have access
      OXIDATION OF CAFFEINE BY CYP1A2: ISOTOPE EFFECTS AND METABOLIC SWITCHING
      Kelly A. Regal, Kent L. Kunze, Raimund M. Peter and Sidney D. Nelson
      Drug Metabolism and Disposition December 2005, 33 (12) 1837-1844; DOI: https://doi.org/10.1124/dmd.105.006031

O

  1. Ohbayashi, Masayuki

    1. You have access
      FUNCTIONAL CHARACTERIZATION OF HUMAN MONOCARBOXYLATE TRANSPORTER 6 (SLC16A5)
      Yuichi Murakami, Noriko Kohyama, Yasuna Kobayashi, Masayuki Ohbayashi, Hisakazu Ohtani, Yasufumi Sawada and Toshinori Yamamoto
      Drug Metabolism and Disposition December 2005, 33 (12) 1845-1851; DOI: https://doi.org/10.1124/dmd.105.005264
  2. Ohtani, Hisakazu

    1. You have access
      FUNCTIONAL CHARACTERIZATION OF HUMAN MONOCARBOXYLATE TRANSPORTER 6 (SLC16A5)
      Yuichi Murakami, Noriko Kohyama, Yasuna Kobayashi, Masayuki Ohbayashi, Hisakazu Ohtani, Yasufumi Sawada and Toshinori Yamamoto
      Drug Metabolism and Disposition December 2005, 33 (12) 1845-1851; DOI: https://doi.org/10.1124/dmd.105.005264
  3. Otagiri, Masaki

    1. You have access
      HYDROLYSIS OF ANGIOTENSIN II RECEPTOR BLOCKER PRODRUG OLMESARTAN MEDOXOMIL BY HUMAN SERUM ALBUMIN AND IDENTIFICATION OF ITS CATALYTIC ACTIVE SITES
      Shen-Feng Ma, Makoto Anraku, Yasunori Iwao, Keishi Yamasaki, Ulrich Kragh-Hansen, Noriyuki Yamaotsu, Shuichi Hirono, Toshihiko Ikeda and Masaki Otagiri
      Drug Metabolism and Disposition December 2005, 33 (12) 1911-1919; DOI: https://doi.org/10.1124/dmd.105.006163
  4. Ozawa, Shogo

    1. You have access
      FUNCTIONAL ANALYSIS OF THREE CYP1A2 VARIANTS FOUND IN A JAPANESE POPULATION
      Yoshiro Saito, Nobumitsu Hanioka, Keiko Maekawa, Takashi Isobe, Yumi Tsuneto, Ryosuke Nakamura, Akiko Soyama, Shogo Ozawa, Toshiko Tanaka-Kagawa, Hideto Jinno, Shizuo Narimatsu and Jun-ichi Sawada
      Drug Metabolism and Disposition December 2005, 33 (12) 1905-1910; DOI: https://doi.org/10.1124/dmd.105.005819

P

  1. Pearce, Robin E.

    1. You have access
      PATHWAYS OF CARBAMAZEPINE BIOACTIVATION IN VITRO: II. THE ROLE OF HUMAN CYTOCHROME P450 ENZYMES IN THE FORMATION OF 2-HYDROXYIMINOSTILBENE
      Robin E. Pearce, Jack P. Uetrecht and J. Steven Leeder
      Drug Metabolism and Disposition December 2005, 33 (12) 1819-1826; DOI: https://doi.org/10.1124/dmd.105.004861
  2. Peter, Raimund M.

    1. You have access
      OXIDATION OF CAFFEINE BY CYP1A2: ISOTOPE EFFECTS AND METABOLIC SWITCHING
      Kelly A. Regal, Kent L. Kunze, Raimund M. Peter and Sidney D. Nelson
      Drug Metabolism and Disposition December 2005, 33 (12) 1837-1844; DOI: https://doi.org/10.1124/dmd.105.006031
  3. Pool, William F.

    1. You have access
      HUMAN IN VITRO GLUTATHIONYL AND PROTEIN ADDUCTS OF CARBAMAZEPINE-10,11-EPOXIDE, A STABLE AND PHARMACOLOGICALLY ACTIVE METABOLITE OF CARBAMAZEPINE
      Hai-Zhi Bu, Ping Kang, Alan J. Deese, Ping Zhao and William F. Pool
      Drug Metabolism and Disposition December 2005, 33 (12) 1920-1924; DOI: https://doi.org/10.1124/dmd.105.006866

R

  1. Rankin, Gary O.

    1. You have access
      TRANSAMINATION IN THE METABOLISM OF THE NEPHROTOXICANT N-(3,5-DICHLOROPHENYL)SUCCINIMIDE IN RATS
      Donghui Cui, Gary O. Rankin and Peter J. Harvison
      Drug Metabolism and Disposition December 2005, 33 (12) 1765-1770; DOI: https://doi.org/10.1124/dmd.105.006593
  2. Rawden, Helen C.

    1. You have access
      PREDICTION OF METABOLIC CLEARANCE USING CRYOPRESERVED HUMAN HEPATOCYTES: KINETIC CHARACTERISTICS FOR FIVE BENZODIAZEPINES
      David Hallifax, Helen C. Rawden, Nancy Hakooz and J. Brian Houston
      Drug Metabolism and Disposition December 2005, 33 (12) 1852-1858; DOI: https://doi.org/10.1124/dmd.105.005389
  3. Reed, James R.

    1. You have access
      SPECIES DIFFERENCES IN THE ELIMINATION OF A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONIST HIGHLIGHTED BY OXIDATIVE METABOLISM OF ITS ACYL GLUCURONIDE
      Christopher J. Kochansky, Yuan-Qing Xia, Sui Wang, Brian Cato, Mellissa Creighton, Stella H. Vincent, Ronald B. Franklin and James R. Reed
      Drug Metabolism and Disposition December 2005, 33 (12) 1894-1904; DOI: https://doi.org/10.1124/dmd.105.004010
  4. Regal, Kelly A.

    1. You have access
      OXIDATION OF CAFFEINE BY CYP1A2: ISOTOPE EFFECTS AND METABOLIC SWITCHING
      Kelly A. Regal, Kent L. Kunze, Raimund M. Peter and Sidney D. Nelson
      Drug Metabolism and Disposition December 2005, 33 (12) 1837-1844; DOI: https://doi.org/10.1124/dmd.105.006031
  5. Richter, K.

    1. You have access
      EFFECT OF PROPIVERINE ON CYTOCHROME P450 ENZYMES: A COCKTAIL INTERACTION STUDY IN HEALTHY VOLUNTEERS
      D. Tomalik-Scharte, A. Jetter, M. Kinzig-Schippers, A. Skott, F. Sörgel, T. Klaassen, D. Kasel, S. Harlfinger, O. Doroshyenko, D. Frank, J. Kirchheiner, M. Bräter, K. Richter, T. Gramatté and U. Fuhr
      Drug Metabolism and Disposition December 2005, 33 (12) 1859-1866; DOI: https://doi.org/10.1124/dmd.105.005272
  6. Rougier, Nathalie

    1. You have access
      SIMULTANEOUS MEASUREMENT OF 23 ISOFORMS FROM THE HUMAN CYTOCHROME P450 FAMILIES 1 TO 3 BY QUANTITATIVE REVERSE TRANSCRIPTASE-POLYMERASE CHAIN REACTION
      Igor Girault, Nathalie Rougier, Christophe Chesné, Rosette Lidereau, Philippe Beaune, Ivan Bieche and Isabelle de Waziers
      Drug Metabolism and Disposition December 2005, 33 (12) 1803-1810; DOI: https://doi.org/10.1124/dmd.105.005173

S

  1. Saito, Yoshiro

    1. You have access
      FUNCTIONAL ANALYSIS OF THREE CYP1A2 VARIANTS FOUND IN A JAPANESE POPULATION
      Yoshiro Saito, Nobumitsu Hanioka, Keiko Maekawa, Takashi Isobe, Yumi Tsuneto, Ryosuke Nakamura, Akiko Soyama, Shogo Ozawa, Toshiko Tanaka-Kagawa, Hideto Jinno, Shizuo Narimatsu and Jun-ichi Sawada
      Drug Metabolism and Disposition December 2005, 33 (12) 1905-1910; DOI: https://doi.org/10.1124/dmd.105.005819
  2. Sakai, Haruko

    1. You have access
      CYP2A6 AND CYP2B6 ARE INVOLVED IN NORNICOTINE FORMATION FROM NICOTINE IN HUMANS: INTERINDIVIDUAL DIFFERENCES IN THESE CONTRIBUTIONS
      Hiroyuki Yamanaka, Miki Nakajima, Tatsuki Fukami, Haruko Sakai, Akiko Nakamura, Miki Katoh, Masataka Takamiya, Yasuhiro Aoki and Tsuyoshi Yokoi
      Drug Metabolism and Disposition December 2005, 33 (12) 1811-1818; DOI: https://doi.org/10.1124/dmd.105.006254
  3. Sasaki, Yasutsuna

    1. You have access
      GEFITINIB (IRESSA) INHIBITS THE CYP3A4-MEDIATED FORMATION OF 7-ETHYL-10-(4-AMINO-1-PIPERIDINO)CARBONYLOXYCAMPTOTHECIN BUT ACTIVATES THAT OF 7-ETHYL-10-[4-N-(5-AMINOPENTANOIC ACID)-1-PIPERIDINO]CARBONYLOXYCAMPTOTHECIN FROM IRINOTECAN
      Ken-ichi Fujita, Yuichi Ando, Masaru Narabayashi, Toshimichi Miya, Fumio Nagashima, Wataru Yamamoto, Keiji Kodama, Kazuhiro Araki, Hisashi Endo and Yasutsuna Sasaki
      Drug Metabolism and Disposition December 2005, 33 (12) 1785-1790; DOI: https://doi.org/10.1124/dmd.105.006205
  4. Saulter, Janelle Y.

    1. You have access
      UNUSUAL DEHYDROXYLATION OF ANTIMICROBIAL AMIDOXIME PRODRUGS BY CYTOCHROME b5 AND NADH CYTOCHROME b5 REDUCTASE
      Janelle Y. Saulter, Joseph R. Kurian, Lauren A. Trepanier, Richard R. Tidwell, Arlene S. Bridges, David W. Boykin, Chad E. Stephens, Mariappan Anbazhagan and James Edwin Hall
      Drug Metabolism and Disposition December 2005, 33 (12) 1886-1893; DOI: https://doi.org/10.1124/dmd.105.005017
  5. Sawada, Jun-ichi

    1. You have access
      FUNCTIONAL ANALYSIS OF THREE CYP1A2 VARIANTS FOUND IN A JAPANESE POPULATION
      Yoshiro Saito, Nobumitsu Hanioka, Keiko Maekawa, Takashi Isobe, Yumi Tsuneto, Ryosuke Nakamura, Akiko Soyama, Shogo Ozawa, Toshiko Tanaka-Kagawa, Hideto Jinno, Shizuo Narimatsu and Jun-ichi Sawada
      Drug Metabolism and Disposition December 2005, 33 (12) 1905-1910; DOI: https://doi.org/10.1124/dmd.105.005819
  6. Sawada, Yasufumi

    1. You have access
      FUNCTIONAL CHARACTERIZATION OF HUMAN MONOCARBOXYLATE TRANSPORTER 6 (SLC16A5)
      Yuichi Murakami, Noriko Kohyama, Yasuna Kobayashi, Masayuki Ohbayashi, Hisakazu Ohtani, Yasufumi Sawada and Toshinori Yamamoto
      Drug Metabolism and Disposition December 2005, 33 (12) 1845-1851; DOI: https://doi.org/10.1124/dmd.105.005264
  7. Schuetz, Erin G.

    1. You have access
      ROLE OF THE NUCLEAR RECEPTOR PREGNANE X RECEPTOR IN ACETAMINOPHEN HEPATOTOXICITY
      Kristina K. Wolf, Sheryl G. Wood, Jane A. Hunt, Brooke W. Walton-Strong, Kazuto Yasuda, Lubin Lan, Su X. Duan, Qin Hao, Steven A. Wrighton, Elizabeth H. Jeffery, Ronald M. Evans, Juliana G. Szakacs, Lisa L. von Moltke, David J. Greenblatt, Michael H. Court, Erin G. Schuetz, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition December 2005, 33 (12) 1827-1836; DOI: https://doi.org/10.1124/dmd.105.005256
  8. Shankar, Kartik

    1. You have access
      SATURATION TOXICOKINETICS OF THIOACETAMIDE: ROLE IN INITIATION OF LIVER INJURY
      Jaya Chilakapati, Kartik Shankar, Midhun C. Korrapati, Ronald A. Hill and Harihara M. Mehendale
      Drug Metabolism and Disposition December 2005, 33 (12) 1877-1885; DOI: https://doi.org/10.1124/dmd.105.005520
  9. Sinclair, Jacqueline F.

    1. You have access
      ROLE OF THE NUCLEAR RECEPTOR PREGNANE X RECEPTOR IN ACETAMINOPHEN HEPATOTOXICITY
      Kristina K. Wolf, Sheryl G. Wood, Jane A. Hunt, Brooke W. Walton-Strong, Kazuto Yasuda, Lubin Lan, Su X. Duan, Qin Hao, Steven A. Wrighton, Elizabeth H. Jeffery, Ronald M. Evans, Juliana G. Szakacs, Lisa L. von Moltke, David J. Greenblatt, Michael H. Court, Erin G. Schuetz, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition December 2005, 33 (12) 1827-1836; DOI: https://doi.org/10.1124/dmd.105.005256
  10. Sinclair, Peter R.

    1. You have access
      ROLE OF THE NUCLEAR RECEPTOR PREGNANE X RECEPTOR IN ACETAMINOPHEN HEPATOTOXICITY
      Kristina K. Wolf, Sheryl G. Wood, Jane A. Hunt, Brooke W. Walton-Strong, Kazuto Yasuda, Lubin Lan, Su X. Duan, Qin Hao, Steven A. Wrighton, Elizabeth H. Jeffery, Ronald M. Evans, Juliana G. Szakacs, Lisa L. von Moltke, David J. Greenblatt, Michael H. Court, Erin G. Schuetz, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition December 2005, 33 (12) 1827-1836; DOI: https://doi.org/10.1124/dmd.105.005256
  11. Skott, A.

    1. You have access
      EFFECT OF PROPIVERINE ON CYTOCHROME P450 ENZYMES: A COCKTAIL INTERACTION STUDY IN HEALTHY VOLUNTEERS
      D. Tomalik-Scharte, A. Jetter, M. Kinzig-Schippers, A. Skott, F. Sörgel, T. Klaassen, D. Kasel, S. Harlfinger, O. Doroshyenko, D. Frank, J. Kirchheiner, M. Bräter, K. Richter, T. Gramatté and U. Fuhr
      Drug Metabolism and Disposition December 2005, 33 (12) 1859-1866; DOI: https://doi.org/10.1124/dmd.105.005272
  12. Skrlin, Sara M.

    1. You have access
      NICOTINE AND 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-BUTANONE METABOLISM BY CYTOCHROME P450 2B6
      Kari E. Dicke, Sara M. Skrlin and Sharon E. Murphy
      Drug Metabolism and Disposition December 2005, 33 (12) 1760-1764; DOI: https://doi.org/10.1124/dmd.105.006718
  13. Sörgel, F.

    1. You have access
      EFFECT OF PROPIVERINE ON CYTOCHROME P450 ENZYMES: A COCKTAIL INTERACTION STUDY IN HEALTHY VOLUNTEERS
      D. Tomalik-Scharte, A. Jetter, M. Kinzig-Schippers, A. Skott, F. Sörgel, T. Klaassen, D. Kasel, S. Harlfinger, O. Doroshyenko, D. Frank, J. Kirchheiner, M. Bräter, K. Richter, T. Gramatté and U. Fuhr
      Drug Metabolism and Disposition December 2005, 33 (12) 1859-1866; DOI: https://doi.org/10.1124/dmd.105.005272
  14. Soyama, Akiko

    1. You have access
      FUNCTIONAL ANALYSIS OF THREE CYP1A2 VARIANTS FOUND IN A JAPANESE POPULATION
      Yoshiro Saito, Nobumitsu Hanioka, Keiko Maekawa, Takashi Isobe, Yumi Tsuneto, Ryosuke Nakamura, Akiko Soyama, Shogo Ozawa, Toshiko Tanaka-Kagawa, Hideto Jinno, Shizuo Narimatsu and Jun-ichi Sawada
      Drug Metabolism and Disposition December 2005, 33 (12) 1905-1910; DOI: https://doi.org/10.1124/dmd.105.005819
  15. Stephens, Chad E.

    1. You have access
      UNUSUAL DEHYDROXYLATION OF ANTIMICROBIAL AMIDOXIME PRODRUGS BY CYTOCHROME b5 AND NADH CYTOCHROME b5 REDUCTASE
      Janelle Y. Saulter, Joseph R. Kurian, Lauren A. Trepanier, Richard R. Tidwell, Arlene S. Bridges, David W. Boykin, Chad E. Stephens, Mariappan Anbazhagan and James Edwin Hall
      Drug Metabolism and Disposition December 2005, 33 (12) 1886-1893; DOI: https://doi.org/10.1124/dmd.105.005017
  16. Szakacs, Juliana G.

    1. You have access
      ROLE OF THE NUCLEAR RECEPTOR PREGNANE X RECEPTOR IN ACETAMINOPHEN HEPATOTOXICITY
      Kristina K. Wolf, Sheryl G. Wood, Jane A. Hunt, Brooke W. Walton-Strong, Kazuto Yasuda, Lubin Lan, Su X. Duan, Qin Hao, Steven A. Wrighton, Elizabeth H. Jeffery, Ronald M. Evans, Juliana G. Szakacs, Lisa L. von Moltke, David J. Greenblatt, Michael H. Court, Erin G. Schuetz, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition December 2005, 33 (12) 1827-1836; DOI: https://doi.org/10.1124/dmd.105.005256

T

  1. Takamiya, Masataka

    1. You have access
      CYP2A6 AND CYP2B6 ARE INVOLVED IN NORNICOTINE FORMATION FROM NICOTINE IN HUMANS: INTERINDIVIDUAL DIFFERENCES IN THESE CONTRIBUTIONS
      Hiroyuki Yamanaka, Miki Nakajima, Tatsuki Fukami, Haruko Sakai, Akiko Nakamura, Miki Katoh, Masataka Takamiya, Yasuhiro Aoki and Tsuyoshi Yokoi
      Drug Metabolism and Disposition December 2005, 33 (12) 1811-1818; DOI: https://doi.org/10.1124/dmd.105.006254
  2. Tam, Vincent H.

    1. You have access
      DISPOSITION OF FLAVONOIDS VIA RECYCLING: COMPARISON OF INTESTINAL VERSUS HEPATIC DISPOSITION
      Jun Chen, Stephen Wang, Xiaobin Jia, Susan Bajimaya, Huimin Lin, Vincent H. Tam and Ming Hu
      Drug Metabolism and Disposition December 2005, 33 (12) 1777-1784; DOI: https://doi.org/10.1124/dmd.105.003673
  3. Tamai, Ikumi

    1. You have access
      INVOLVEMENT OF URIC ACID TRANSPORTER IN INCREASED RENAL CLEARANCE OF THE XANTHINE OXIDASE INHIBITOR OXYPURINOL INDUCED BY A URICOSURIC AGENT, BENZBROMARONE
      Takashi Iwanaga, Daisuke Kobayashi, Masamichi Hirayama, Tomoji Maeda and Ikumi Tamai
      Drug Metabolism and Disposition December 2005, 33 (12) 1791-1795; DOI: https://doi.org/10.1124/dmd.105.006056
  4. Tanaka-Kagawa, Toshiko

    1. You have access
      FUNCTIONAL ANALYSIS OF THREE CYP1A2 VARIANTS FOUND IN A JAPANESE POPULATION
      Yoshiro Saito, Nobumitsu Hanioka, Keiko Maekawa, Takashi Isobe, Yumi Tsuneto, Ryosuke Nakamura, Akiko Soyama, Shogo Ozawa, Toshiko Tanaka-Kagawa, Hideto Jinno, Shizuo Narimatsu and Jun-ichi Sawada
      Drug Metabolism and Disposition December 2005, 33 (12) 1905-1910; DOI: https://doi.org/10.1124/dmd.105.005819
  5. Tang, Cuyue

    1. You have access
      GLYCOSIDATION OF AN ENDOTHELIN ETA RECEPTOR ANTAGONIST AND DICLOFENAC IN HUMAN LIVER MICROSOMES: AGLYCONE-DEPENDENT UDP-SUGAR SELECTIVITY
      Cuyue Tang and Bennett Ma
      Drug Metabolism and Disposition December 2005, 33 (12) 1796-1802; DOI: https://doi.org/10.1124/dmd.105.005801
  6. Tidwell, Richard R.

    1. You have access
      UNUSUAL DEHYDROXYLATION OF ANTIMICROBIAL AMIDOXIME PRODRUGS BY CYTOCHROME b5 AND NADH CYTOCHROME b5 REDUCTASE
      Janelle Y. Saulter, Joseph R. Kurian, Lauren A. Trepanier, Richard R. Tidwell, Arlene S. Bridges, David W. Boykin, Chad E. Stephens, Mariappan Anbazhagan and James Edwin Hall
      Drug Metabolism and Disposition December 2005, 33 (12) 1886-1893; DOI: https://doi.org/10.1124/dmd.105.005017
  7. Tomalik-Scharte, D.

    1. You have access
      EFFECT OF PROPIVERINE ON CYTOCHROME P450 ENZYMES: A COCKTAIL INTERACTION STUDY IN HEALTHY VOLUNTEERS
      D. Tomalik-Scharte, A. Jetter, M. Kinzig-Schippers, A. Skott, F. Sörgel, T. Klaassen, D. Kasel, S. Harlfinger, O. Doroshyenko, D. Frank, J. Kirchheiner, M. Bräter, K. Richter, T. Gramatté and U. Fuhr
      Drug Metabolism and Disposition December 2005, 33 (12) 1859-1866; DOI: https://doi.org/10.1124/dmd.105.005272
  8. Torres, Rhoda

    1. You have access
      BIOACTIVATION OF 4-METHYLPHENOL (p-CRESOL) VIA CYTOCHROME P450-MEDIATED AROMATIC OXIDATION IN HUMAN LIVER MICROSOMES
      Zhengyin Yan, H. Marlon Zhong, Noureddine Maher, Rhoda Torres, Gregory C. Leo, Gary W. Caldwell and Norman Huebert
      Drug Metabolism and Disposition December 2005, 33 (12) 1867-1876; DOI: https://doi.org/10.1124/dmd.105.006387
  9. Trepanier, Lauren A.

    1. You have access
      UNUSUAL DEHYDROXYLATION OF ANTIMICROBIAL AMIDOXIME PRODRUGS BY CYTOCHROME b5 AND NADH CYTOCHROME b5 REDUCTASE
      Janelle Y. Saulter, Joseph R. Kurian, Lauren A. Trepanier, Richard R. Tidwell, Arlene S. Bridges, David W. Boykin, Chad E. Stephens, Mariappan Anbazhagan and James Edwin Hall
      Drug Metabolism and Disposition December 2005, 33 (12) 1886-1893; DOI: https://doi.org/10.1124/dmd.105.005017
  10. Tsuneto, Yumi

    1. You have access
      FUNCTIONAL ANALYSIS OF THREE CYP1A2 VARIANTS FOUND IN A JAPANESE POPULATION
      Yoshiro Saito, Nobumitsu Hanioka, Keiko Maekawa, Takashi Isobe, Yumi Tsuneto, Ryosuke Nakamura, Akiko Soyama, Shogo Ozawa, Toshiko Tanaka-Kagawa, Hideto Jinno, Shizuo Narimatsu and Jun-ichi Sawada
      Drug Metabolism and Disposition December 2005, 33 (12) 1905-1910; DOI: https://doi.org/10.1124/dmd.105.005819

U

  1. Uetrecht, Jack P.

    1. You have access
      PATHWAYS OF CARBAMAZEPINE BIOACTIVATION IN VITRO: II. THE ROLE OF HUMAN CYTOCHROME P450 ENZYMES IN THE FORMATION OF 2-HYDROXYIMINOSTILBENE
      Robin E. Pearce, Jack P. Uetrecht and J. Steven Leeder
      Drug Metabolism and Disposition December 2005, 33 (12) 1819-1826; DOI: https://doi.org/10.1124/dmd.105.004861

V

  1. Vincent, Stella H.

    1. You have access
      SPECIES DIFFERENCES IN THE ELIMINATION OF A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONIST HIGHLIGHTED BY OXIDATIVE METABOLISM OF ITS ACYL GLUCURONIDE
      Christopher J. Kochansky, Yuan-Qing Xia, Sui Wang, Brian Cato, Mellissa Creighton, Stella H. Vincent, Ronald B. Franklin and James R. Reed
      Drug Metabolism and Disposition December 2005, 33 (12) 1894-1904; DOI: https://doi.org/10.1124/dmd.105.004010
  2. von Moltke, Lisa L.

    1. You have access
      ROLE OF THE NUCLEAR RECEPTOR PREGNANE X RECEPTOR IN ACETAMINOPHEN HEPATOTOXICITY
      Kristina K. Wolf, Sheryl G. Wood, Jane A. Hunt, Brooke W. Walton-Strong, Kazuto Yasuda, Lubin Lan, Su X. Duan, Qin Hao, Steven A. Wrighton, Elizabeth H. Jeffery, Ronald M. Evans, Juliana G. Szakacs, Lisa L. von Moltke, David J. Greenblatt, Michael H. Court, Erin G. Schuetz, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition December 2005, 33 (12) 1827-1836; DOI: https://doi.org/10.1124/dmd.105.005256

W

  1. Walton-Strong, Brooke W.

    1. You have access
      ROLE OF THE NUCLEAR RECEPTOR PREGNANE X RECEPTOR IN ACETAMINOPHEN HEPATOTOXICITY
      Kristina K. Wolf, Sheryl G. Wood, Jane A. Hunt, Brooke W. Walton-Strong, Kazuto Yasuda, Lubin Lan, Su X. Duan, Qin Hao, Steven A. Wrighton, Elizabeth H. Jeffery, Ronald M. Evans, Juliana G. Szakacs, Lisa L. von Moltke, David J. Greenblatt, Michael H. Court, Erin G. Schuetz, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition December 2005, 33 (12) 1827-1836; DOI: https://doi.org/10.1124/dmd.105.005256
  2. Wang, Stephen

    1. You have access
      DISPOSITION OF FLAVONOIDS VIA RECYCLING: COMPARISON OF INTESTINAL VERSUS HEPATIC DISPOSITION
      Jun Chen, Stephen Wang, Xiaobin Jia, Susan Bajimaya, Huimin Lin, Vincent H. Tam and Ming Hu
      Drug Metabolism and Disposition December 2005, 33 (12) 1777-1784; DOI: https://doi.org/10.1124/dmd.105.003673
  3. Wang, Sui

    1. You have access
      SPECIES DIFFERENCES IN THE ELIMINATION OF A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONIST HIGHLIGHTED BY OXIDATIVE METABOLISM OF ITS ACYL GLUCURONIDE
      Christopher J. Kochansky, Yuan-Qing Xia, Sui Wang, Brian Cato, Mellissa Creighton, Stella H. Vincent, Ronald B. Franklin and James R. Reed
      Drug Metabolism and Disposition December 2005, 33 (12) 1894-1904; DOI: https://doi.org/10.1124/dmd.105.004010
  4. Wolf, Kristina K.

    1. You have access
      ROLE OF THE NUCLEAR RECEPTOR PREGNANE X RECEPTOR IN ACETAMINOPHEN HEPATOTOXICITY
      Kristina K. Wolf, Sheryl G. Wood, Jane A. Hunt, Brooke W. Walton-Strong, Kazuto Yasuda, Lubin Lan, Su X. Duan, Qin Hao, Steven A. Wrighton, Elizabeth H. Jeffery, Ronald M. Evans, Juliana G. Szakacs, Lisa L. von Moltke, David J. Greenblatt, Michael H. Court, Erin G. Schuetz, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition December 2005, 33 (12) 1827-1836; DOI: https://doi.org/10.1124/dmd.105.005256
  5. Wood, Sheryl G.

    1. You have access
      ROLE OF THE NUCLEAR RECEPTOR PREGNANE X RECEPTOR IN ACETAMINOPHEN HEPATOTOXICITY
      Kristina K. Wolf, Sheryl G. Wood, Jane A. Hunt, Brooke W. Walton-Strong, Kazuto Yasuda, Lubin Lan, Su X. Duan, Qin Hao, Steven A. Wrighton, Elizabeth H. Jeffery, Ronald M. Evans, Juliana G. Szakacs, Lisa L. von Moltke, David J. Greenblatt, Michael H. Court, Erin G. Schuetz, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition December 2005, 33 (12) 1827-1836; DOI: https://doi.org/10.1124/dmd.105.005256
  6. Wrighton, Steven A.

    1. You have access
      ROLE OF THE NUCLEAR RECEPTOR PREGNANE X RECEPTOR IN ACETAMINOPHEN HEPATOTOXICITY
      Kristina K. Wolf, Sheryl G. Wood, Jane A. Hunt, Brooke W. Walton-Strong, Kazuto Yasuda, Lubin Lan, Su X. Duan, Qin Hao, Steven A. Wrighton, Elizabeth H. Jeffery, Ronald M. Evans, Juliana G. Szakacs, Lisa L. von Moltke, David J. Greenblatt, Michael H. Court, Erin G. Schuetz, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition December 2005, 33 (12) 1827-1836; DOI: https://doi.org/10.1124/dmd.105.005256

X

  1. Xia, Yuan-Qing

    1. You have access
      SPECIES DIFFERENCES IN THE ELIMINATION OF A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONIST HIGHLIGHTED BY OXIDATIVE METABOLISM OF ITS ACYL GLUCURONIDE
      Christopher J. Kochansky, Yuan-Qing Xia, Sui Wang, Brian Cato, Mellissa Creighton, Stella H. Vincent, Ronald B. Franklin and James R. Reed
      Drug Metabolism and Disposition December 2005, 33 (12) 1894-1904; DOI: https://doi.org/10.1124/dmd.105.004010

Y

  1. Yamamoto, Toshinori

    1. You have access
      FUNCTIONAL CHARACTERIZATION OF HUMAN MONOCARBOXYLATE TRANSPORTER 6 (SLC16A5)
      Yuichi Murakami, Noriko Kohyama, Yasuna Kobayashi, Masayuki Ohbayashi, Hisakazu Ohtani, Yasufumi Sawada and Toshinori Yamamoto
      Drug Metabolism and Disposition December 2005, 33 (12) 1845-1851; DOI: https://doi.org/10.1124/dmd.105.005264
  2. Yamamoto, Wataru

    1. You have access
      GEFITINIB (IRESSA) INHIBITS THE CYP3A4-MEDIATED FORMATION OF 7-ETHYL-10-(4-AMINO-1-PIPERIDINO)CARBONYLOXYCAMPTOTHECIN BUT ACTIVATES THAT OF 7-ETHYL-10-[4-N-(5-AMINOPENTANOIC ACID)-1-PIPERIDINO]CARBONYLOXYCAMPTOTHECIN FROM IRINOTECAN
      Ken-ichi Fujita, Yuichi Ando, Masaru Narabayashi, Toshimichi Miya, Fumio Nagashima, Wataru Yamamoto, Keiji Kodama, Kazuhiro Araki, Hisashi Endo and Yasutsuna Sasaki
      Drug Metabolism and Disposition December 2005, 33 (12) 1785-1790; DOI: https://doi.org/10.1124/dmd.105.006205
  3. Yamanaka, Hiroyuki

    1. You have access
      CYP2A6 AND CYP2B6 ARE INVOLVED IN NORNICOTINE FORMATION FROM NICOTINE IN HUMANS: INTERINDIVIDUAL DIFFERENCES IN THESE CONTRIBUTIONS
      Hiroyuki Yamanaka, Miki Nakajima, Tatsuki Fukami, Haruko Sakai, Akiko Nakamura, Miki Katoh, Masataka Takamiya, Yasuhiro Aoki and Tsuyoshi Yokoi
      Drug Metabolism and Disposition December 2005, 33 (12) 1811-1818; DOI: https://doi.org/10.1124/dmd.105.006254
  4. Yamaotsu, Noriyuki

    1. You have access
      HYDROLYSIS OF ANGIOTENSIN II RECEPTOR BLOCKER PRODRUG OLMESARTAN MEDOXOMIL BY HUMAN SERUM ALBUMIN AND IDENTIFICATION OF ITS CATALYTIC ACTIVE SITES
      Shen-Feng Ma, Makoto Anraku, Yasunori Iwao, Keishi Yamasaki, Ulrich Kragh-Hansen, Noriyuki Yamaotsu, Shuichi Hirono, Toshihiko Ikeda and Masaki Otagiri
      Drug Metabolism and Disposition December 2005, 33 (12) 1911-1919; DOI: https://doi.org/10.1124/dmd.105.006163
  5. Yamasaki, Keishi

    1. You have access
      HYDROLYSIS OF ANGIOTENSIN II RECEPTOR BLOCKER PRODRUG OLMESARTAN MEDOXOMIL BY HUMAN SERUM ALBUMIN AND IDENTIFICATION OF ITS CATALYTIC ACTIVE SITES
      Shen-Feng Ma, Makoto Anraku, Yasunori Iwao, Keishi Yamasaki, Ulrich Kragh-Hansen, Noriyuki Yamaotsu, Shuichi Hirono, Toshihiko Ikeda and Masaki Otagiri
      Drug Metabolism and Disposition December 2005, 33 (12) 1911-1919; DOI: https://doi.org/10.1124/dmd.105.006163
  6. Yan, Zhengyin

    1. You have access
      BIOACTIVATION OF 4-METHYLPHENOL (p-CRESOL) VIA CYTOCHROME P450-MEDIATED AROMATIC OXIDATION IN HUMAN LIVER MICROSOMES
      Zhengyin Yan, H. Marlon Zhong, Noureddine Maher, Rhoda Torres, Gregory C. Leo, Gary W. Caldwell and Norman Huebert
      Drug Metabolism and Disposition December 2005, 33 (12) 1867-1876; DOI: https://doi.org/10.1124/dmd.105.006387
  7. Yasuda, Kazuto

    1. You have access
      ROLE OF THE NUCLEAR RECEPTOR PREGNANE X RECEPTOR IN ACETAMINOPHEN HEPATOTOXICITY
      Kristina K. Wolf, Sheryl G. Wood, Jane A. Hunt, Brooke W. Walton-Strong, Kazuto Yasuda, Lubin Lan, Su X. Duan, Qin Hao, Steven A. Wrighton, Elizabeth H. Jeffery, Ronald M. Evans, Juliana G. Szakacs, Lisa L. von Moltke, David J. Greenblatt, Michael H. Court, Erin G. Schuetz, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition December 2005, 33 (12) 1827-1836; DOI: https://doi.org/10.1124/dmd.105.005256
  8. Yokoi, Tsuyoshi

    1. You have access
      CYP2A6 AND CYP2B6 ARE INVOLVED IN NORNICOTINE FORMATION FROM NICOTINE IN HUMANS: INTERINDIVIDUAL DIFFERENCES IN THESE CONTRIBUTIONS
      Hiroyuki Yamanaka, Miki Nakajima, Tatsuki Fukami, Haruko Sakai, Akiko Nakamura, Miki Katoh, Masataka Takamiya, Yasuhiro Aoki and Tsuyoshi Yokoi
      Drug Metabolism and Disposition December 2005, 33 (12) 1811-1818; DOI: https://doi.org/10.1124/dmd.105.006254

Z

  1. Zhao, Ping

    1. You have access
      HUMAN IN VITRO GLUTATHIONYL AND PROTEIN ADDUCTS OF CARBAMAZEPINE-10,11-EPOXIDE, A STABLE AND PHARMACOLOGICALLY ACTIVE METABOLITE OF CARBAMAZEPINE
      Hai-Zhi Bu, Ping Kang, Alan J. Deese, Ping Zhao and William F. Pool
      Drug Metabolism and Disposition December 2005, 33 (12) 1920-1924; DOI: https://doi.org/10.1124/dmd.105.006866
  2. Zhong, H. Marlon

    1. You have access
      BIOACTIVATION OF 4-METHYLPHENOL (p-CRESOL) VIA CYTOCHROME P450-MEDIATED AROMATIC OXIDATION IN HUMAN LIVER MICROSOMES
      Zhengyin Yan, H. Marlon Zhong, Noureddine Maher, Rhoda Torres, Gregory C. Leo, Gary W. Caldwell and Norman Huebert
      Drug Metabolism and Disposition December 2005, 33 (12) 1867-1876; DOI: https://doi.org/10.1124/dmd.105.006387
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 33 (12)
Drug Metabolism and Disposition
Vol. 33, Issue 12
1 Dec 2005
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics